Stock screener

VNDA

Conviction 28HealthcareScan · Mon, Aug 10, 2026
Hammer
VNDA$5.04+0.80%
ResistanceSupportVol 14
63 bars
Vol MA14 1.2M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Vanda Pharmaceuticals Inc.PHARMACEUTICAL PREPARATIONSwww.vandapharma.com
Price5.04
Change+0.80%
Gap-0.60%
Rel volume4.03×
Avg volume1.11M
Avg $ vol5.84M
SMA 205.29
SMA 505.77
SMA 2006.52
Price vs 50-12.68%
Price vs 200-22.69%
MA stackbearish
50/200 cross
Supertrenddown · 5.68
RSI (14)37
MACD hist0.00
MACD crossbull · 0d
Stoch %K / %D55 / 56
ADX (14)37
+DI / −DI10 / 39
RSI divergence
MACD divergenceBullish
ATR %+5.29%
ADR %4.77%
52w high9.56
52w low4.19
From 52w high-47.28%
Above 52w low+20.29%
New 52w highNo
SqueezeOff
Bollinger width17.60%
%B0.23
Donchian pos37.80%
Donchian high6.02
Donchian low4.45
AVWAP (52w high)6.73
vs AVWAP high-25.11%
AVWAP (52w low)7.02
vs AVWAP low-28.18%
OBV trendFlat
Chaikin MF (20)0.11
Today vs 20d4.03×
Avg vol (14d)1.2M
Avg vol (20d)1.11M
Avg $ vol (20d)5.84M
Market cap304.73M
RS 3m (vs SPY)-27.45%
RS 6m (vs SPY)-44.96%
RS line new highNo
Trend template2/8
Technical rank10.9
1 week-3.63%
1 month-19.23%
3 months-19.75%
6 months-33.42%
1 year+20.00%
YTD-38.91%
P/E-1.38
P/B1.38
P/S1.41
P/FCF-2.76
EPS-3.74
Div yield
ROE-100.13%
ROA-53.45%
Debt/Eq
Current1.61
EV/EBITDA-1.65
Gross margin28.17%
Net margin-102.02%
Rev growth8.72%
EPS growth-1066.53%
Price target14.33
Target upside184.33%
Analyst ratingBuy
Institutional85.45%
Ent. value248.85M
Revenue50.53M
Net income-62.51M
Gross profit
Free cash flow-110.44M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out60.14M
Employees533
ListedWed, Apr 12, 2006
Free float51.85M
Float %87.7%
Short interest7.19M
Days to cover8.8d
Short volume41.6%
Squeeze score69 / 100
Next earnings
EPS forecast
Last EPS vs est−$1.04 vs −$0.51
Last surprise-103.9% miss
Setup gradeD
Conviction28 / 100
Pattern quality
Tech rank10.9 / 100
Group rank86 / 100 · Leading
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmHammer
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VNDA

All disclosures →
No recent disclosed trades by Congress in VNDA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VNDA · 8 buys · 1 sell

InsiderSideShares
Mitchell Stephen Ray
Director · Common Stock · 2026-06-04
Grant41.6K
Chrousos Phaedra
Director · Common Stock · 2026-06-04
Grant41.6K
Ward Anne Sempowski
Director · Common Stock · 2026-06-04
Grant41.6K
Honore Tage
Director · Common Stock · 2026-06-04
Grant41.6K
DUGAN RICHARD W
Director · Common Stock · 2026-06-04
Grant41.6K
Duncan Charles Cliff
Director · Common Stock · 2026-06-04
Grant41.6K
McGuire Daniel Patrick
SVP, GC and Secretary · Common Stock · 2026-06-04
Grant80K
Mitchell Stephen Ray
Director · Common Stock · 2026-05-18
Gift25.84K
Duncan Charles Cliff
Director · Common Stock · 2026-04-22
Grant57.1K

SEC filings

EDGAR filings in VNDA · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.